In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...

Nearly 40,000 people in Khyber-Pakhtunkhwa are currently living with HIV/AIDS, while 15 to 20 new cases are being reported daily, provincial health officials revealed on World AIDS Day.Speaking at a ...

An FDA‑approved medication called spironolactone, often prescribed as a diuretic, or water pill, for heart and blood pressure ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read more on GILD stock here.

South Africa has taken a major step forward in expanding its HIV-prevention toolbox, with the Department of Health confirming that the National Essential Medicines List Committee (NEMLC) has approved ...

Merck (MRK) announced on Wednesday that its single-tablet antiviral regimen, doravirine and islatravir for adults with HIV, was found to be non-inferior to Gilead’s (GILD) once-daily HIV pill Biktarvy ...

Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global health officials call a game-changer. The drug developed by Gilead ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV who are on complex treatment regimens, according to BMO Capital Markets. A ...

fDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA gDepartment of Epidemiology, The Johns Hopkins Bloomberg School ...